EUVIMEDEUVIMED entdecken
Crossref

Immunogenicity and Efficacy of an Accelerated Vaccination Schedule Against Hepatitis E Virus Infection in Rabbits

Fan Zhang iD, Zuliang Shi, Yihan Wu, Jianbo Xia, Ling Wang iD

Journal of Medical Virology · 2025-02 · 97 (2)

DOI: 10.1002/jmv.70218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 10.02.2025. Verfasst von Fan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Scie…. Hauptthemen laut MEDLINE: Hepatitis E, Immunization Schedule, Hepatitis E virus, Viral Hepatitis Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: This work was supported by the National Natural Science Foundation of China under Grant 81772175 and the Natural Science Foundation of Hubei Province of China….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An important goal of the hepatitis E virus (HEV) vaccine is to prevent HEV in fragile, conflict‐affected, and vulnerable (FCV) settings with documented HEV circulation, but the routine hepatitis E vaccination schedule (0, 1, and 6 months) might not provide adequate protection for them in time. Therefore, in this study, we aimed to evaluate the immunogenicity and efficacy of a HEV vaccine (HEV 239 vaccine, Hecolin) using an accelerated vaccination schedule (vaccine doses at 0 and 7 days). Two doses of accelerated vaccination schedule (0 and 7 days) induced high titers of anti‐HEV protective antibodies in a short period of time in rabbits of the vaccine group, which could protect the rabbits from HEV infection compared with the infection group. Our results suggest that an accelerated vaccination schedule (0 and 7 days) could provide protective antibodies in a shorter time. The accelerated schedule should be further recommended for use as a backup in FCV settings or during a hepatitis E outbreak.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis EImmunization ScheduleHepatitis E virusViral Hepatitis VaccinesVaccinationImmunogenicity, VaccineAnimalsRabbitsHepatitis AntibodiesVaccines, SyntheticAntibodies, ViralVaccine Efficacy

Stichwörter der Autor:innen

hepatitis Ehepatitis E viruspreventionvaccine

Substanzen

Hepatitis AntibodiesViral Hepatitis VaccineshecolinVaccines, SyntheticAntibodies, Viral

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

ORCID-Profile: Fan Zhang, Ling Wang

Förderung

  • This work was supported by the National Natural Science Foundation of China under Grant 81772175 and the Natural Science Foundation of Hubei Province of China…

Zitieren

APA

Zhang, F., Shi, Z., Wu, Y., Xia, J., & Wang, L. (2025). Immunogenicity and Efficacy of an Accelerated Vaccination Schedule Against Hepatitis E Virus Infection in Rabbits. Journal of Medical Virology, 97(2). https://doi.org/10.1002/jmv.70218

Vancouver

Zhang F, Shi Z, Wu Y, Xia J, Wang L. Immunogenicity and Efficacy of an Accelerated Vaccination Schedule Against Hepatitis E Virus Infection in Rabbits. Journal of Medical Virology. 2025;97(2). doi:10.1002/jmv.70218

BibTeX
@article{Zhang2025,
  author = {Zhang, Fan and Shi, Zuliang and Wu, Yihan and Xia, Jianbo and Wang, Ling},
  title = {Immunogenicity and Efficacy of an Accelerated Vaccination Schedule Against Hepatitis E Virus Infection in Rabbits},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {2},
  doi = {10.1002/jmv.70218}
}
Kostenlos starten →